Details of the Drug

General Information of Drug (ID: DMLFA3T)

• Drug Name: NX-201
• Synonyms: NXD-20001; P21 activated kinase inhibitors (type 2 neurofibromatosis, fragile X syndrome/autism); P21 activated kinase inhibitors (type 2 neurofibromatosis, fragile X syndrome/autism), NexGenix; Pak inhibitors (type 2 neurofibromatosis/fragile X syndrome/autism), NexGenix

Indication

Disease Entry	ICD 11	Status	REF
Autism spectrum disorder	6A02	Investigative	[1]

• Cross-matching ID: TTD ID: D0K7BF

References

• [1] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.